Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Baxalta's Vonvendi is first FDA-approved recombinant von Willebrand factor

Dec. 9, 2015

Biotest cleared for phase III evaluation of BT-524 fibrinogen concentrate

Dec. 7, 2015

Coagadex now available in U.S.

Dec. 4, 2015

Shionogi's Mulpleta launched in Japan

Dec. 3, 2015

Medshine Discovery and North China Pharmaceutical report FXa inhibitors

Dec. 2, 2015

FDA clears IND application for SB-FIX

Dec. 2, 2015

Baxalta's Adynovate launched for the treatment of hemophilia in adult patients

Dec. 1, 2015

SMRX-11: A clot-specific streptokinase

Dec. 1, 2015

European Commission approves Praxbind

Nov. 26, 2015

Global Blood Therapeutics develops kallikrein inhibitors

Nov. 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
In monkeys, enhanced TB vaccine dissolves after inducing protection
BioWorld Science
An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...